{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T09:19:09Z","timestamp":1753521549250},"reference-count":45,"publisher":"The Society for Free Radical Research Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2020]]},"DOI":"10.3164\/jcbn.19-125","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T22:05:22Z","timestamp":1583445922000},"page":"213-223","source":"Crossref","is-referenced-by-count":8,"title":["Bone marrow-derived humoral factors suppress oxidative phosphorylation, upregulate TSG-6, and improve therapeutic effects on liver injury of mesenchymal stem cells"],"prefix":"10.3164","volume":"66","author":[{"given":"Takashi","family":"Miyaji","sequence":"first","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Yamaguchi University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Takami","sequence":"additional","affiliation":[{"name":"Department of Liver Regenerative Medicine, Yamaguchi University Graduate School of Medicine"},{"name":"Center for Regenerative and Cell Therapy, Yamaguchi University Organization for Research Initiatives"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Fujisawa","sequence":"additional","affiliation":[{"name":"Department of Liver Regenerative Medicine, Yamaguchi University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Oncology and Laboratory Medicine, Yamaguchi University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Health Administration Center, Yamaguchi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Sakaida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Yamaguchi University Graduate School of Medicine"},{"name":"Center for Regenerative and Cell Therapy, Yamaguchi University Organization for Research Initiatives"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: an update. Cell Transplant 2016; 25: 829\u2013848.","DOI":"10.3727\/096368915X689622"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell 2011; 9: 11\u201315.","DOI":"10.1016\/j.stem.2011.06.008"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Lee RH, Pulin AA, Seo MJ, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009; 5: 54\u201363.","DOI":"10.1016\/j.stem.2009.05.003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Krasnodembskaya A, Song Y, Fang X, et al. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 2010; 28: 2229\u20132238.","DOI":"10.1002\/stem.544"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Young PP, Sch\u00e4fer R. Cell-based therapies for cardiac disease: a cellular therapist\u2019s perspective. Transfusion 2015; 55: 441\u2013451.","DOI":"10.1111\/trf.12826"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Peired AJ, Sisti A, Romagnani P. Mesenchymal stem cell-based therapy for kidney disease: a review of clinical evidence. Stem Cells Int 2016; 2016: 4798639.","DOI":"10.1155\/2016\/4798639"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Liu KD, Wilson JG, Zhuo H, et al. Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1\/2 trial of human mesenchymal stem\/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome. Ann Intensive Care 2014; 4: 22.","DOI":"10.1186\/s13613-014-0022-z"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Terai S, Ishikawa T, Omori K, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006; 24: 2292\u20132298.","DOI":"10.1634\/stemcells.2005-0542"},{"key":"9","unstructured":"9 Takami T, Terai S, Sakaida I. Advanced therapies using autologous bone marrow cells for chronic liver disease. Discov Med 2012; 14: 7\u201312."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Shin TH, Lee S, Choi KR, et al. Quality and freshness of human bone marrow-derived mesenchymal stem cells decrease over time after trypsinization and storage in phosphate-buffered saline. Sci Rep 2017; 7: 1106.","DOI":"10.1038\/s41598-017-01315-0"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Agata H, Asahina I, Watanabe N, et al. Characteristic change and loss of <i>in vivo <\/i>osteogenic abilities of human bone marrow stromal cells during passage. Tissue Eng Part A 2010; 16: 663\u2013673.","DOI":"10.1089\/ten.tea.2009.0500"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Block TJ, Marinkovic M, Tran ON, et al. Restoring the quantity and quality of elderly human mesenchymal stem cells for autologous cell-based therapies. Stem Cell Res Ther 2017; 8: 239.","DOI":"10.1186\/s13287-017-0688-x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Soleimani M, Nadri S. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc 2009; 4: 102\u2013106.","DOI":"10.1038\/nprot.2008.221"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Wang J, Ju B, Pan C, et al. Application of bone marrow-derived mesenchymal stem cells in the treatment of intrauterine adhesions in rats. Cell Physiol Biochem 2016; 39: 1553\u20131560.","DOI":"10.1159\/000447857"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Zhu H, Guo ZK, Jiang XX, et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc 2010; 5: 550\u2013560.","DOI":"10.1038\/nprot.2009.238"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Guo Q, Chen Y, Guo L, Jiang T, Lin Z. miR-23a\/b regulates the balance between osteoblast and adipocyte differentiation in bone marrow mesenchymal stem cells. Bone Res 2016; 4: 16022.","DOI":"10.1038\/boneres.2016.22"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Yeung DK, Griffith JF, Antonio GE, Lee FK, Woo J, Leung PC.  Osteoporosis is associated with increased marrow fat content and decreased marrow fat unsaturation: a proton MR spectroscopy study. J Magn Reson Imaging 2005; 22: 279\u2013285.","DOI":"10.1002\/jmri.20367"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Cordes C, Baum T, Dieckmeyer M, et al. MR-based assessment of bone marrow fat in osteoporosis, diabetes, and obesity. Front Endocrinol (Lausanne) 2016; 7: 74.","DOI":"10.3389\/fendo.2016.00074"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Ramani R, Megason G, Schallheim J, et al. Integrative analysis of microRNA-mediated gene signatures and pathways modulating white blood cell count in childhood acute lymphoblastic leukemia. Biomark Insights 2017; 12: 1177271917702895.","DOI":"10.1177\/1177271917702895"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Kilpinen L, Parmar A, Greco D, et al. Expansion induced microRNA changes in bone marrow mesenchymal stromal cells reveals interplay between immune regulation and cell cycle. Aging (Albany NY) 2016; 8: 2799\u20132813.","DOI":"10.18632\/aging.101088"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Verdin E, Hirschey MD, Finley LW, Haigis MC. Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem Sci 2010; 35: 669\u2013675.","DOI":"10.1016\/j.tibs.2010.07.003"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Folmes CD, Nelson TJ, Martinez-Fernandez A, et al. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab 2011; 14: 264\u2013271.","DOI":"10.1016\/j.cmet.2011.06.011"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006; 3: 177\u2013185.","DOI":"10.1016\/j.cmet.2006.02.002"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Majmundar AJ, Wong WJ, Simon MC. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 2010; 40: 294\u2013309.","DOI":"10.1016\/j.molcel.2010.09.022"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Soni S, Padwad YS. HIF-1 in cancer therapy: two decade long story of a transcription factor. Acta Oncol 2017; 56: 503\u2013515.","DOI":"10.1080\/0284186X.2017.1301680"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Mimeault M, Batra SK. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells. J Cell Mol Med 2013; 17: 30\u201354.","DOI":"10.1111\/jcmm.12004"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Martinez VG, Ontoria-Oviedo I, Ricardo CP, et al. Overexpression of hypoxia-inducible factor 1 alpha improves immunomodulation by dental mesenchymal stem cells. Stem Cell Res Ther 2017; 8: 208.","DOI":"10.1186\/s13287-017-0659-2"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Iwai K, Yamanaka K, Kamura T, et al. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc Natl Acad Sci U S A 1999; 96: 12436\u201312441.","DOI":"10.1073\/pnas.96.22.12436"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Lisztwan J, Imbert G, Wirbelauer C, Gstaiger M, Krek W. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes Dev 1999; 13: 1822\u20131833.","DOI":"10.1101\/gad.13.14.1822"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Kallio PJ, Pongratz I, Gradin K, McGuire J, Poellinger L. Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc Natl Acad Sci U S A 1997; 94: 5667\u20135672.","DOI":"10.1073\/pnas.94.11.5667"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Brugarolas J, Lei K, Hurley RL, et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex. Genes Dev 2004; 18: 2893\u20132904.","DOI":"10.1101\/gad.1256804"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Hudson CC, Liu M, Chiang GG, et al. Regulation of hypoxia-inducible factor 1\u03b1 expression and function by the mammalian target of rapamycin. Mol Cell Biol 2002; 22: 7004\u20137014.","DOI":"10.1128\/MCB.22.20.7004-7014.2002"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 2002; 277: 38205\u201338211.","DOI":"10.1074\/jbc.M203781200"},{"key":"34","unstructured":"34 Jiang BH, Jiang G, Zheng JZ, Lu Z, Hunter T, Vogt PK. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ 2001; 12: 363\u2013369."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Milner CM, Day AJ. TSG-6: a multifunctional protein associated with inflammation. J Cell Sci 2003; 116 (Pt 10): 1863\u20131873.","DOI":"10.1242\/jcs.00407"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Lee RH, Yu JM, Foskett AM, et al. TSG-6 as a biomarker to predict efficacy of human mesenchymal stem\/progenitor cells (hMSCs) in modulating sterile inflammation <i>in vivo<\/i>. Proc Natl Acad Sci U S A 2014; 111: 16766\u201316771.","DOI":"10.1073\/pnas.1416121111"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Wang S, Lee C, Kim J, et al. Tumor necrosis factor-inducible gene 6 protein ameliorates chronic liver damage by promoting autophagy formation in mice. Exp Mol Med 2017; 49: e380.","DOI":"10.1038\/emm.2017.140"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Romano B, Elangovan S, Erreni M, et al. TNF-stimulated gene-6 (TSG-6) is a key regulator in switching stemness and biological properties of mesenchymal stem cells. Stem Cells 2019; 37: 973\u2013987.","DOI":"10.1002\/stem.3010"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Theise ND, Nimmakayalu M, Gardner R, et al. Liver from bone marrow in humans. Hepatology 2000; 32: 11\u201316.","DOI":"10.1053\/jhep.2000.9124"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Bihari C, Anand L, Rooge S, et al. Bone marrow stem cells and their niche components are adversely affected in advanced cirrhosis of the liver. Hepatology 2016; 64: 1273\u20131288.","DOI":"10.1002\/hep.28754"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 M\u00e9ndez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010; 466: 829\u2013834.","DOI":"10.1038\/nature09262"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Takase HM, Itoh T, Ino S, et al. FGF7 is a functional niche signal required for stimulation of adult liver progenitor cells that support liver regeneration. Genes Dev 2013; 27: 169\u2013181.","DOI":"10.1101\/gad.204776.112"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Katsumata LW, Miyajima A, Itoh T. Portal fibroblasts marked by the surface antigen Thy1 contribute to fibrosis in mouse models of cholestatic liver injury. Hepatol Commun 2017; 1: 198\u2013214.","DOI":"10.1002\/hep4.1023"},{"key":"44","unstructured":"44 Du H, Yu H, Yang Y, et al. Computational identification of microRNAs and their targets in liver cirrhosis. Oncol Lett 2017; 14: 7691\u20137698."},{"key":"45","unstructured":"45 Shen Y, Liu M, Chen C, Lai X, Zhang M. MicroRNA profile changes in liraglutide treated steatotic HepG2 cells. Int J Clin Exp Med 2017; 10: 4856\u20134864."}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/66\/3\/66_19-125\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T07:06:26Z","timestamp":1588835186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/66\/3\/66_19-125\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.19-125","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}